241 results on '"Annerén, Göran"'
Search Results
202. Donor chimerism across full allogenic barriers achieved by in utero transplantation of fetal mesenchymal stem cells in a case of osteogenesis imperfecta
- Author
-
Westgren, Lars, Anneren, Göran, Axelsson, Ove, Evald, Uwe, LeBlanc, Katarina, and Ringden, Olle
- Published
- 2003
- Full Text
- View/download PDF
203. Prader‐Willi syndrome in a child with a balanced (X;15) de novo translocation
- Author
-
Gustavson, Karl‐Henrik, primary, Annerén, Göran, additional, and Jagell, Sten, additional
- Published
- 1984
- Full Text
- View/download PDF
204. PC-based system for classifying dysmorphic syndromes in children
- Author
-
Wiener, Fred, primary and Annerén, Göran, additional
- Published
- 1989
- Full Text
- View/download PDF
205. A novel quantitative targeted analysis of X-chromosome inactivation (XCI) using nanopore sequencing.
- Author
-
Johansson, Josefin, Lidéus, Sarah, Höijer, Ida, Ameur, Adam, Gudmundsson, Sanna, Annerén, Göran, Bondeson, Marie-Louise, and Wilbe, Maria
- Subjects
- *
NANOPORES , *ANDROGEN receptors , *QUANTITATIVE research , *RETINITIS pigmentosa - Abstract
X-chromosome inactivation (XCI) analyses often assist in diagnostics of X-linked traits, however accurate assessment remains challenging with current methods. We developed a novel strategy using amplification-free Cas9 enrichment and Oxford nanopore technologies sequencing called XCI-ONT, to investigate and rigorously quantify XCI in human androgen receptor gene (AR) and human X-linked retinitis pigmentosa 2 gene (RP2). XCI-ONT measures methylation over 116 CpGs in AR and 58 CpGs in RP2, and separate parental X-chromosomes without PCR bias. We show the usefulness of the XCI-ONT strategy over the PCR-based golden standard XCI technique that only investigates one or two CpGs per gene. The results highlight the limitations of using the golden standard technique when the XCI pattern is partially skewed and the advantages of XCI-ONT to rigorously quantify XCI. This study provides a universal XCI-method on DNA, which is highly valuable in clinical and research framework of X-linked traits. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
206. More severe intellectual disability found in teenagers compared to younger children with Down syndrome.
- Author
-
Wester Oxelgren, Ulrika, Myrelid, Åsa, Annerén, Göran, Westerlund, Joakim, Gustafsson, Jan, and Fernell, Elisabeth
- Subjects
- *
DOWN syndrome , *DISABILITIES , *INTELLECTUAL disabilities , *ATTENTION-deficit hyperactivity disorder , *TEENAGERS - Abstract
Aim: We investigated the severities and profiles of intellectual disability (ID) in a population-based group of children with Down syndrome and related the findings to coexisting autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD).Methods: There were about 100 children with Down syndrome living in Uppsala County, Sweden, at the time of the study who all received medical services from the same specialist outpatient clinic. The 60 children (68% male) were aged 5-17 years at inclusion: 41 were assessed within the study and 19 had test results from previous assessments, performed within three years before inclusion. We compared two age groups: 5-12 and 13-18 years old.Results: Of the 60 children, 49 were assessed with a cognitive test and the 11 children who could not participate in formal tests had clinical assessments. Mild ID was found in 9% of the older children and in 35% of the younger children. Severe ID was found in 91% of the older children and 65% of the younger children. Verbal and nonverbal domains did not differ.Conclusion: Intellectual level was lower in the older children and patients with Down syndrome need to be followed during childhood with regard to their ID levels. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
207. Prevalence of autism and attention-deficit-hyperactivity disorder in Down syndrome: a population-based study.
- Author
-
Oxelgren, Ulrika Wester, Myrelid, Åsa, Annerén, Göran, Ekstam, Bodil, Göransson, Cathrine, Holmbom, Agneta, Isaksson, Anne, Åberg, Marie, Gustafsson, Jan, and Fernell, Elisabeth
- Subjects
- *
AUTISM spectrum disorders in children , *INTELLECTUAL disabilities , *NEUROBEHAVIORAL disorders , *DISEASE prevalence , *NEURODEVELOPMENTAL treatment , *DIAGNOSIS , *ATTENTION-deficit hyperactivity disorder , *AUTISM , *HEALTH planning , *LONGITUDINAL method , *NEUROLOGIC examination , *PSYCHOLOGICAL tests , *DOWN syndrome , *DISEASE complications ,PEOPLE with Down syndrome - Abstract
Aim: To investigate the prevalence of autism spectrum disorder (ASD) and attention-deficit-hyperactivity disorder (ADHD) in a population-based group of children and adolescents with Down syndrome, and to relate the findings to level of intellectual disability and to medical conditions.Method: From a population-based cohort of 60 children and adolescents with Down syndrome, 41 individuals (29 males, 12 females; mean age 11y, age range 5-17y) for whom parents gave consent for participation were clinically assessed with regard to ASD and ADHD. The main instruments used were the Autism Diagnostic Interview-Revised, Autism Diagnostic Observation Schedule, Swanson, Nolan, and Pelham-IV Rating Scale, and the Adaptive Behavior Assessment System-II.Results: High rates of ASD and ADHD were found: 17 (42%) and 14 (34%) of the 41 children met DSM criteria for ASD and ADHD respectively.Interpretation: Children with Down syndrome and coexisting neurodevelopmental/neuropsychiatric disorders in addition to intellectual disability and medical disorders constitute a severely disabled group. Based on the results, we suggest that screening is implemented for both ASD and ADHD, at the age of 3 to 5 years and early school years respectively, to make adequate interventions possible. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
208. Information and knowledge about Down syndrome among women and partners after first trimester combined testing.
- Author
-
Ternby, Ellen, Ingvoldstad, Charlotta, Annerén, Göran, Lindgren, Peter, and Axelsson, Ove
- Subjects
- *
DOWN syndrome , *FIRST trimester of pregnancy , *ULTRASONIC imaging , *BIOCHEMISTRY , *COHORT analysis - Abstract
We assessed reasons among women and partners for choosing combined ultrasound-biochemistry testing, information and knowledge about Down syndrome and decisions concerning invasive procedures and termination of pregnancy in a prospective cohort study in Uppsala County. In all 105 pregnant women and 104 partners coming for a combined ultrasound-biochemistry test answered a questionnaire. The most common reason for a combined ultrasound-biochemistry test was 'to perform all tests possible to make sure the baby is healthy'. Internet and midwives were the most common sources of information. Seventy-two percent had not received information on what it means to live with a child with Down syndrome. Many expectant parents perceived information as insufficient. Both women and partners had varying or low levels of knowledge about medical, cognitive and social consequences of Down syndrome. Twenty-five percent had not decided on an invasive test if indicated and only 42% would consider termination of pregnancy with a Down syndrome diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
209. Unbalanced translocation 9;16 in two children with dysmorphic features, and severe developmental delay: Evidence of cross-over within derivative chromosome 9 in patient #1
- Author
-
Zambrano, Regina M., Wohler, Elizabeth, Annerén, Göran, Thuresson, Ann-Charlotte, Cutting, Garry R., and Batista, Denise A.
- Subjects
- *
CHROMOSOMAL translocation , *DEVELOPMENTAL delay , *FLUORESCENCE in situ hybridization , *CHROMOSOME abnormalities , *COMPARATIVE genomic hybridization , *NUCLEOTIDE sequence - Abstract
Abstract: We describe 2 children with dysmorphic features, and severe developmental delay presenting with overlapping unbalanced translocations of 9q34.3 and 16p13. Patient #1: A 4 year old African-American female with normal karyotype with a pericentric inversion on one chromosome 9 known to be a benign variant. Low resolution array CGH revealed a single BAC clone loss at 9q34.3 and a single BAC clone gain at 16p13.3, confirmed by FISH. Whole genome SNP array analysis refined these findings, identifying a terminal 1.28 Mb deletion (138,879,862–140,164,310) of 9q34.3 and a terminal 1.62 Mb duplication (45,320–1,621,753) of 16p13.3. Sub-telomeric FISH showed an unbalanced cryptic translocation involving the inverted chromosome 9 and chromosome 16. FISH of the father showed a balanced t(9;16)(q34.3;p13.3) involving the non-inverted chromosome 9, and a pericentric inversion on the normal 9 homologous chromosome. The presence of two rearrangements on chromosome 9, both an unbalanced translocation and a pericentric inversion, indicates recombination between the inverted and derivative 9 homologues from her father. Patient #2: A 1 year old Iraqi-Moroccan female with normal karyotype. Array-CGH identified a 0.56 Mb deletion of 9q34.3 (139,586,637–140,147,760) and an 11.31 Mb duplication of 16p13.3p13.13 (31,010–11,313,519). Maternal FISH showed a balanced t(9;16)(q34.3;p13.13). Both patients present with similar clinical phenotype. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
210. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
- Author
-
Laan, Loora, Klar, Joakim, Sobol, Maria, Hoeber, Jan, Shahsavani, Mansoureh, Kele, Malin, Fatima, Ambrin, Zakaria, Muhammad, Annerén, Göran, Falk, Anna, Schuster, Jens, and Dahl, Niklas
- Subjects
- *
DNA methylation , *DEVELOPMENTAL neurobiology , *TRANSCRIPTION factors , *DOWN syndrome , *INDUCED pluripotent stem cells , *HUMAN chromosomes , *NEURAL development - Abstract
Background: Down syndrome (DS) is characterized by neurodevelopmental abnormalities caused by partial or complete trisomy of human chromosome 21 (T21). Analysis of Down syndrome brain specimens has shown global epigenetic and transcriptional changes but their interplay during early neurogenesis remains largely unknown. We differentiated induced pluripotent stem cells (iPSCs) established from two DS patients with complete T21 and matched euploid donors into two distinct neural stages corresponding to early- and mid-gestational ages. Results: Using the Illumina Infinium 450K array, we assessed the DNA methylation pattern of known CpG regions and promoters across the genome in trisomic neural iPSC derivatives, and we identified a total of 500 stably and differentially methylated CpGs that were annotated to CpG islands of 151 genes. The genes were enriched within the DNA binding category, uncovering 37 factors of importance for transcriptional regulation and chromatin structure. In particular, we observed regional epigenetic changes of the transcription factor genes ZNF69, ZNF700 and ZNF763 as well as the HOXA3, HOXB3 and HOXD3 genes. A similar clustering of differential methylation was found in the CpG islands of the HIST1 genes suggesting effects on chromatin remodeling. Conclusions: The study shows that early established differential methylation in neural iPSC derivatives with T21 are associated with a set of genes relevant for DS brain development, providing a novel framework for further studies on epigenetic changes and transcriptional dysregulation during T21 neurogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
211. Autism needs to be considered in children with Down Syndrome.
- Author
-
Wester Oxelgren, Ulrika, Åberg, Marie, Myrelid, Åsa, Annerén, Göran, Westerlund, Joakim, Gustafsson, Jan, and Fernell, Elisabeth
- Subjects
- *
DOWN syndrome , *AUTISM spectrum disorders , *AUTISM , *AUTISM in children , *DISABILITIES , *RESEARCH , *RESEARCH methodology , *EVALUATION research , *MEDICAL cooperation , *SEVERITY of illness index , *COMPARATIVE studies , *RESEARCH funding , *PEOPLE with intellectual disabilities , *LONGITUDINAL method , *DISEASE complications - Abstract
Aim: To analyse levels and profiles of autism symptoms in children with Down Syndrome (DS) with and without diagnosed autism spectrum disorder (ASD) and to specifically study the groups with severe Intellectual Disability (ID).Methods: From a population-based cohort of 60 children with DS (age 5-17 years) with 41 participating children, scores obtained from the Autism Diagnostic Observation Schedule (ADOS) Module-1 algorithm were compared between those with and without diagnosed ASD. Children with DS and ASD were also compared to a cohort of children with idiopathic ASD, presented in the ADOS manual.Results: Children with DS and ASD had significantly higher ADOS scores in all domains compared to those without ASD. When the groups with DS, with and without ASD, were restricted to those with severe ID, the difference remained. When the children with DS and ASD and the idiopathic autism group were compared, the ADOS profiles were similar.Conclusion: A considerable proportion of children with DS has ASD, but there is also a group of children with DS and severe ID without autism. There is a need to increase awareness of the high prevalence of autism in children with DS to ensure that appropriate measures and care are provided. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
212. Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth.
- Author
-
Frisk, Sofia, Taylan, Fulya, Blaszczyk, Izabela, Nennesmo, Inger, Annerén, Göran, Herm, Bettina, Stattin, Eva‐Lena, Zachariadis, Vasilios, Lindstrand, Anna, Tesi, Bianca, Laurell, Tobias, and Nordgren, Ann
- Subjects
- *
NEMALINE myopathy , *MUSCLE growth , *ARM , *SOMATIC mutation , *EMBRYOLOGY , *POLYMERASE chain reaction - Abstract
PIK3CA‐related overgrowth spectrum is a group of rare genetic disorders with asymmetric overgrowth caused by somatic mosaic PIK3CA mutations. Here, we report clinical data and molecular findings from two patients with congenital muscular upper limb overgrowth and aberrant anatomy. During debulking surgery, numerous ectopic muscles were found in the upper limbs of the patients. DNA sequencing, followed by digital polymerase chain reaction, was performed on DNA extracted from biopsies from hypertrophic ectopic muscles and identified the somatic mosaic PIK3CA hotspot mutations c.3140A > G, p.(His1047Arg) and c.1624G > A, p.(Glu542Lys) in a male (patient 1) and a female (patient 2) patient, respectively. Patient 1 had four ectopic muscles and unilateral isolated muscular overgrowth while patient 2 had 13 ectopic muscles and bilateral isolated muscular overgrowth of both upper limbs, indicating that her mutation occurred at early pre‐somitic mesoderm state. The finding of PIK3CA mutations in ectopic muscles highlights the importance of PIK3CA in cell fate in early human embryonic development. Moreover, our findings provide evidence that the disease phenotype depends on the timing of PIK3CA mutagenesis during embryogenesis and confirm the diagnostic entity PIK3CA‐related muscular overgrowth with ectopic accessory muscles. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
213. An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study.
- Author
-
Oxelgren, Ulrika Wester, Westerlund, Joakim, Myrelid, Åsa, Annerén, Göran, Johansson, Lotta, Åberg, Marie, Gustafsson, Jan, and Fernell, Elisabeth
- Subjects
- *
PARENT-child communication , *AUTISTIC people , *CHILDREN , *TEENAGERS , *DOWN syndrome - Abstract
Purpose: To evaluate whether an intervention, targeting deficits in social communication, interaction and restricted activities in children and adolescents with Down syndrome and autism could lead to enhanced participation in family and school activities. Methods: The intervention included education for parents and school staff about autism, and workshops to identify social-communication and daily living activities that would be meaningful for the child to practice at home and at school. Thereafter, a three-month period of training for the child followed. Outcome measures comprised evaluation of goal achievement for each child, the "Family Strain Index" questionnaire and a visual scale pertaining to the parents' general opinion about the intervention. Results: On average, more than 90% of the goals were (to some extent or completely) achieved at home and at school. The mean scores of the "Family Strain Index" were almost identical at the follow-up to those before intervention. The evaluation supported that the use of strategies, intended to facilitate activities and communication, remained largely 18 months after start of the intervention. Conclusion: Despite the group involved in this study being composed of older children and adolescents, most of whom had severe and profound intellectual disability, the goal achievements and parents' views on the intervention were encouraging. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
214. Exome sequencing in Crisponi/cold‐induced sweating syndrome–like individuals reveals unpredicted alternative diagnoses.
- Author
-
Angius, Andrea, Uva, Paolo, Oppo, Manuela, Buers, Insa, Persico, Ivana, Onano, Stefano, Cuccuru, Gianmauro, Van Allen, Margot I., Hulait, Gurdip, Aubertin, Gudrun, Muntoni, Francesco, Fry, Andrew E., Annerén, Göran, Stattin, Eva‐Lena, Palomares‐Bralo, María, Santos‐Simarro, Fernando, Cucca, Francesco, Crisponi, Giangiorgio, Rutsch, Frank, and Crisponi, Laura
- Subjects
- *
SWEATING-sickness , *CRISPONI syndrome , *RARE diseases , *GENETIC disorders , *GENETIC mutation , *EXOMES , *DEVELOPMENTAL delay , *MUSCLE hypotonia - Abstract
Crisponi/cold‐induced sweating syndrome (CS/CISS) is a rare autosomal recessive disorder characterized by a complex phenotype (hyperthermia and feeding difficulties in the neonatal period, followed by scoliosis and paradoxical sweating induced by cold since early childhood) and a high neonatal lethality. CS/CISS is a genetically heterogeneous disorder caused by mutations in CRLF1 (CS/CISS1), CLCF1 (CS/CISS2) and KLHL7 (CS/CISS‐like). Here, a whole exome sequencing approach in individuals with CS/CISS‐like phenotype with unknown molecular defect revealed unpredicted alternative diagnoses. This approach identified putative pathogenic variations in NALCN, MAGEL2 and SCN2A. They were already found implicated in the pathogenesis of other syndromes, respectively the congenital contractures of the limbs and face, hypotonia, and developmental delay syndrome, the Schaaf‐Yang syndrome, and the early infantile epileptic encephalopathy‐11 syndrome. These results suggest a high neonatal phenotypic overlap among these disorders and will be very helpful for clinicians. Genetic analysis of these genes should be considered for those cases with a suspected CS/CISS during neonatal period who were tested as mutation negative in the known CS/CISS genes, because an expedited and corrected diagnosis can improve patient management and can provide a specific clinical follow‐up. Genetic analysis of NALCN, MAGEL2 and SCN2A should be considered for those cases with a suspected Crisponi/cold‐induced sweating syndrome (CS/CISS) during neonatal period who were tested as mutation negative in the known CS/CISS genes, because an expedited and corrected diagnosis can improve patient management and can provide a specific clinical follow‐up. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
215. Mutation in NRAS in familial Noonan syndrome - case report and review of the literature.
- Author
-
Ekvall, Sara, Wilbe, Maria, Dahlgren, Jovanna, Legius, Eric, van Haeringen, Arie, Westphal, Otto, Annerén, Göran, and Bondeson, Marie-Louise
- Subjects
- *
NOONAN syndrome , *SHORT stature , *MITOGEN-activated protein kinases , *LEUKEMIA , *GENETIC testing - Abstract
Background: Noonan syndrome (NS), a heterogeneous developmental disorder associated with variable clinical expression including short stature, congenital heart defect, unusual pectus deformity and typical facial features, is caused by activating mutations in genes involved in the RAS-MAPK signaling pathway. Case presentation: Here, we present a clinical and molecular characterization of a small family with Noonan syndrome. Comprehensive mutation analysis of NF1, PTPN11, SOS1, CBL, BRAF, RAF1, SHOC2, MAP2K2, MAP2K1, SPRED1, NRAS, HRAS and KRAS was performed using targeted next-generation sequencing. The result revealed a recurrent mutation in NRAS, c.179G > A (p.G60E), in the index patient. This mutation was inherited from the index patient's father, who also showed signs of NS. Conclusions: We describe clinical features in this family and review the literature for genotype-phenotype correlations for NS patients with mutations in NRAS. Neither of affected individuals in this family presented with juvenile myelomonocytic leukemia (JMML), which together with previously published results suggest that the risk for NS individuals with a germline NRAS mutation developing JMML is not different from the proportion seen in other NS cases. Interestingly, 50 % of NS individuals with an NRAS mutation (including our family) present with lentigines and/or Café-au-lait spots. This demonstrates a predisposition to hyperpigmented lesions in NRAS-positive NS individuals. In addition, the affected father in our family presented with a hearing deficit since birth, which together with lentigines are two characteristics of NS with multiple lentigines (previously LEOPARD syndrome), supporting the difficulties in diagnosing individuals with RASopathies correctly. The clinical and genetic heterogeneity observed in RASopathies is a challenge for genetic testing. However, next-generation sequencing technology, which allows screening of a large number of genes simultaneously, will facilitate an early and accurate diagnosis of patients with RASopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
216. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
- Author
-
Schuster, Jens, Halvardson, Jonatan, Pilar Lorenzo, Laureanne, Ameur, Adam, Sobol, Maria, Raykova, Doroteya, Annerén, Göran, Feuk, Lars, and Dahl, Niklas
- Subjects
- *
PLURIPOTENT stem cells , *STEM cells , *MULTIPOTENT stem cells , *INDUCED pluripotent stem cells , *DISEASES - Abstract
Induced pluripotent stem cell (iPSC) technology has become an important tool for disease modeling. Insufficient data on the variability among iPSC lines derived from a single somatic parental cell line have in practice led to generation and analysis of several, usually three, iPSC sister lines from each parental cell line. We established iPSC lines from a human fibroblast line (HDF-K1) and used transcriptome sequencing to investigate the variation among three sister lines (iPSC-K1A, B, and C). For comparison, we analyzed the transcriptome of an iPSC line (iPSC-K5B) derived from a different fibroblast line (HDF-K5), a human embryonic stem cell (ESC) line (ESC-HS181), as well as the two parental fibroblast lines. All iPSC lines fulfilled stringent criteria for pluripotency. In an unbiased cluster analysis, all stem cell lines (four iPSCs and one ESC) clustered together as opposed to the parental fibroblasts. The transcriptome profiles of the three iPSC sister lines were indistinguishable from each other, and functional pathway analysis did not reveal any significant hits. In contrast, the expression profiles of the ESC line and the iPSC-K5B line were distinct from that of the sister lines iPSC-K1A, B, and C. Differentiation to embryoid bodies and subsequent analysis of germ layer markers in the five stem cell clones confirmed that the distribution of their expression profiles was retained. Taken together, our observations stress the importance of using iPSCs of different parental origin rather than several sister iPSC lines to distinguish disease-associated mechanisms from genetic background effects in disease modeling. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
217. Identification of three novel FGF16 mutations in X-linked recessive fusion of the fourth and fifth metacarpals and possible correlation with heart disease.
- Author
-
Laurell, Tobias, Nilsson, Daniel, Hofmeister, Wolfgang, Lindstrand, Anna, Ahituv, Nadav, Vandermeer, Julia, Amilon, Anders, Annerén, Göran, Arner, Marianne, Pettersson, Maria, Jäntti, Nina, Rosberg, Hans‐Eric, Cattini, Peter A., Nordenskjöld, Agneta, Mäkitie, Outi, Grigelioniene, Giedre, and Nordgren, Ann
- Subjects
- *
GENETIC mutation , *CARDIOPULMONARY system , *HEART diseases , *HANDEDNESS , *HUMAN abnormalities - Abstract
Nonsense mutations in FGF16 have recently been linked to X-linked recessive hand malformations with fusion between the fourth and the fifth metacarpals and hypoplasia of the fifth digit ( MF4; MIM#309630). The purpose of this study was to perform careful clinical phenotyping and to define molecular mechanisms behind X-linked recessive MF4 in three unrelated families. We performed whole-exome sequencing, and identified three novel mutations in FGF16. The functional impact of FGF16 loss was further studied using morpholino-based suppression of fgf16 in zebrafish. In addition, clinical investigations revealed reduced penetrance and variable expressivity of the MF4 phenotype. Cardiac disorders, including myocardial infarction and atrial fibrillation followed the X-linked FGF16 mutated trait in one large family. Our findings establish that a mutation in exon 1, 2 or 3 of FGF16 results in X-linked recessive MF4 and expand the phenotypic spectrum of FGF16 mutations to include a possible correlation with heart disease. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
218. Genotype–phenotype analysis of 18q12.1-q12.2 copy number variation in autism.
- Author
-
Wang, Peter, Carrion, Prescilla, Qiao, Ying, Tyson, Christine, Hrynchak, Monica, Calli, Kristina, Lopez-Rangel, Elena, Andrieux, Joris, Delobel, Bruno, Duban-Bedu, Bénédicte, Thuresson, Ann-Charlotte, Annerén, Göran, Liu, Xudong, Rajcan-Separovic, Evica, and Suzanne Lewis, M.E.
- Subjects
- *
DNA copy number variations , *GENETICS of autism , *PHENOTYPES , *AUTISM spectrum disorders , *NEURODEVELOPMENTAL treatment , *SOCIAL interaction , *DISEASE susceptibility ,TREATMENT of developmental disabilities - Abstract
Abstract: Autism Spectrum Disorders (ASD) are complex neurodevelopmental conditions characterized by delays in social interactions and communication as well as displays of restrictive/repetitive interests. DNA copy number variants have been identified as a genomic susceptibility factor in ASDs and imply significant genetic heterogeneity. We report a 7-year-old female with ADOS-G and ADI-R confirmed autistic disorder harbouring a de novo 4 Mb duplication (18q12.1). Our subject displays severely deficient expressive language, stereotypic and repetitive behaviours, mild intellectual disability (ID), focal epilepsy, short stature and absence of significant dysmorphic features. Search of the PubMed literature and DECIPHER database identified 4 additional cases involving 18q12.1 associated with autism and/or ID that overlap our case: one duplication, two deletions and one balanced translocation. Notably, autism and ID are seen with genomic gain or loss at 18q12.1, plus epilepsy and short stature in duplication cases, and hypotonia and tall stature in deletion cases. No consistent dysmorphic features were noted amongst the reviewed cases. We review prospective ASD/ID candidate genes integral to 18q12.1, including those coding for the desmocollin/desmoglein cluster, ring finger proteins 125 and 138, trafficking protein particle complex 8 and dystrobrevin-alpha. The collective clinical and molecular features common to microduplication 18q12.1 suggest that dosage-sensitive, position or contiguous gene effects may be associated in the etiopathogenesis of this autism-ID-epilepsy syndrome. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
219. A novel microdeletion syndrome at 9q21.13 characterised by mental retardation, speech delay, epilepsy and characteristic facial features
- Author
-
Boudry-Labis, Elise, Demeer, Bénédicte, Le Caignec, Cédric, Isidor, Bertrand, Mathieu-Dramard, Michèle, Plessis, Ghislaine, George, Alice M., Taylor, Juliet, Aftimos, Salim, Wiemer-Kruel, Adelheid, Kohlhase, Jürgen, Annerén, Göran, Firth, Helen, Simonic, Ingrid, Vermeesch, Joris, Thuresson, Ann-Charlotte, Copin, Henri, Love, Donald R., and Andrieux, Joris
- Subjects
- *
DELETION mutation , *INTELLECTUAL disabilities , *SPEECH disorders , *EPILEPSY , *SINGLE nucleotide polymorphisms , *DNA microarrays , *GENETIC disorder diagnosis - Abstract
Abstract: The increased use of array-CGH and SNP-arrays for genetic diagnosis has led to the identification of new microdeletion/microduplication syndromes and enabled genotype–phenotype correlations to be made. In this study, nine patients with 9q21 deletions were investigated and compared with four previously Decipher reported patients. Genotype–phenotype comparisons of 13 patients revealed several common major characteristics including significant developmental delay, epilepsy, neuro-behavioural disorders and recognizable facial features including hypertelorism, feature-less philtrum, and a thin upper lip. The molecular investigation identified deletions with different breakpoints and of variable lengths, but the 750 kb smallest overlapping deleted region includes four genes. Among these genes, RORB is a strong candidate for a neurological phenotype. To our knowledge, this is the first published report of 9q21 microdeletions and our observations strongly suggest that these deletions are responsible for a new genetic syndrome characterised by mental retardation with speech delay, epilepsy, autistic behaviour and moderate facial dysmorphy. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
220. De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature
- Author
-
Becker, Kerstin, Di Donato, Nataliya, Holder-Espinasse, Muriel, Andrieux, Joris, Cuisset, Jean-Marie, Vallée, Louis, Plessis, Ghislaine, Jean, Nolwenn, Delobel, Bruno, Thuresson, Ann-Charlotte, Annerén, Göran, Ravn, Kirstine, Tümer, Zeynep, Tinschert, Sigrid, Schrock, Evelin, Jønch, Aia Elise, and Hackmann, Karl
- Subjects
- *
INTELLECTUAL disabilities , *DELETION mutation , *CHROMOSOME abnormalities , *LITERATURE reviews , *PHENOTYPES , *DEVELOPMENTAL delay , *GENETICS - Abstract
Abstract: Interstitial 6q deletions can cause a variable phenotype depending on the size and location of the deletion. 6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip. In this study we describe two patients with overlapping 6q14 deletions presenting with developmental delay and characteristic dysmorphism. Molecular karyotyping using array CGH analysis revealed a de novo 8.9 Mb deletion at 6q14.1-q14.3 and a de novo 11.3 Mb deletion at 6q12.1-6q14.1, respectively. We provide a review of the clinical features of twelve other patients with 6q14 deletions detected by array CGH analysis. By assessing all reported data we could not identify a single common region of deletion. Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
221. Investigation of gene dosage imbalances in patients with Noonan syndrome using multiplex ligation-dependent probe amplification analysis
- Author
-
Nyström, Anna-Maja, Ekvall, Sara, Thuresson, Ann-Charlotte, Denayer, Ellen, Legius, Eric, Kamali-Moghaddam, Masood, Westermark, Bengt, Annerén, Göran, and Bondeson, Marie-Louise
- Subjects
- *
GENETIC disorders , *ETIOLOGY of diseases , *GENE amplification , *GENETIC mutation , *ETIOLOGY of cancer , *CARCINOGENESIS , *MITOGEN-activated protein kinases , *RAS oncogenes - Abstract
Abstract: The RAS-MAPK syndromes are a group of clinically and genetically related disorders caused by dysregulation of the RAS-MAPK pathway. A member of this group of disorders, Noonan syndrome (NS), is associated with several different genes within the RAS-MAPK pathway. To date, mutations in PTPN11, SOS1, KRAS, RAF1 and SHOC2 are known to cause NS and a small group of patients harbour mutations in BRAF, MEK1 or NRAS. The majority of the mutations are predicted to cause an up-regulation of the pathway; hence they are gain-of-function mutations. Despite recent advances in gene identification in NS, the genetic aetiology is still unknown in about ¼ of patients. To investigate the contribution of gene dosage imbalances of RAS-MAPK-related genes to the pathogenesis of NS, a multiplex ligation-dependent probe amplification (MLPA) assay was developed. Two probe sets were designed for seven RAS-MAPK-syndrome-related candidate genes: PTPN11, SOS1, RAF1, KRAS, BRAF, MEK1 and MEK2. The probe sets were validated in 15 healthy control individuals and in glioma tumour cell lines. Subsequently, 44 NS patients negative for mutations in known NS-associated genes were screened using the two probe sets. The MLPA results for the patients revealed no gene dosage imbalances. In conclusion, the present results exclude copy number variation of PTPN11, SOS1, RAF1, KRAS, BRAF, MEK1 and MEK2 as a common pathogenic mechanism of NS. The validated and optimised RAS-MAPK probe sets presented here enable rapid high throughput screening of further patients with RAS-MAPK syndromes. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
222. Clinical variability of the 22q11.2 duplication syndrome
- Author
-
Wentzel, Christian, Fernström, Maria, Öhrner, Ylva, Annerén, Göran, and Thuresson, Ann-Charlotte
- Subjects
- *
INTELLECTUAL disabilities , *PATHOLOGICAL psychology , *DEVELOPMENTAL disabilities , *LEARNING disabilities - Abstract
Abstract: The 22q11.2 duplication syndrome is an extremely variable disorder with a phenotype ranging from normal to learning disability and congenital defects. Both patients with a de novo 22q11.2 duplication and patients in whom the duplication has been inherited from a phenotypically normal parent have been reported. In this study we present two familial cases with a 3Mb 22q11.2 duplication detected by array-CGH. We also review the findings in 36 reported cases with the aim of delineating the phenotype of the 22q11.2 duplication syndrome. In a majority of the reported cases where parents have been tested, the duplication seems to have been inherited from a normal parent with minor abnormalities. With this in mind we recommend that family members of patients with a 22q11.2 duplication to be tested for this genetic defect. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
223. Severe psychomotor retardation in a boy with a supernumerary derivative chromosome resulting in partial trisomy 21 and partial trisomy 7p
- Author
-
Ahlbom, Bodil Edman, Wahlström, Jan, Saalman, Robert, Wadelius, Claes, and Annerén, Göran
- Subjects
- *
DOWN syndrome , *CHROMOSOMES , *GENETICS , *DEVELOPMENTAL disabilities , *PATIENTS - Abstract
We report on a 12-year-old boy with a supernumerary chromosome der(21)t(7; 21)(p21; q21.3)mat, resulting in a partial trisomy 21 and a partial trisomy 7p. The patient has a severe psychomotor retardation. Although he has most of chromosome 21 in three copies, he does not have a phenotype of Down syndrome (DS). In addition to cytogenetic analysis, molecular analysis confirmed that the ”DS critical region” on chromosome 21 (21q22) is not present in three copies, since the breakpoint of the partial trisomy 21 was found to be located distal to the marker locus D21S145 but proximal to D21S226. The patient''s severe mental retardation is probably due to the small telomeric 7p trisomy, having the breakpoint between markers D7S507 and D7S488. In comparison with previously published cases of partial trisomy 7p, the phenotype of this patient indicates that there is a region around the distal part of band 7p21 that in three copies might contribute to many of the facial features common to patients with partial trisomy 7p. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
224. Trisomy 4q syndrome: presentation of a new case and review of the literature.
- Author
-
Lundin, Catarina, Zech, Lore, Sjörs, Kerstin, Wadelius, Claes, and Annerén, Göran
- Subjects
- *
TRISOMY , *CHROMOSOMES , *MICROSATELLITE repeats - Abstract
We describe the 11th case of a de novo partial trisomy of the long arm of chromosome 4, with the extra segment spanning from 4q27 to 4q35. The aberration resulted from an unbalanced translocation of material from 4q to the short arm of chromosome 7, as evident from fluorescent in situ hybridization. Microsatellite analysis revealed the extra material to originate from the father. The karyotype was interpreted as 46,XX,der(7)t(4;7)(q27;p22). The patient is a 13-year-old girl with severe mental retardation, growth retardation, hearing impairment as well as minor foot, thumb and facial anomalies. Although the extent of the aberration varies between the reported patients, there are nevertheless features in common, suggestive of a trisomy 4q syndrome. The clinical findings most frequently reported are: mental retardation, seizures, microcephaly, hearing impairment and growth retardation, as well as epicanthic folds, high/broad/depressed nasal bridge, malformed ears, tooth and thumb anomalies. Almost the entire long arm of chromosome 4, except band q11, has been involved in trisomies/duplications, but 4q27 and 4q31 seem to be preferentially engaged in the trisomy 4q syndrome. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
225. Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions.
- Author
-
Johansson J, Lidéus S, Frykholm C, Gunnarsson C, Mihalic F, Gudmundsson S, Ekvall S, Molin AM, Pham M, Vihinen M, Lagerstedt-Robinson K, Nordgren A, Jemth P, Ameur A, Annerén G, Wilbe M, and Bondeson ML
- Subjects
- Female, Humans, Heterogeneous-Nuclear Ribonucleoproteins genetics, Heterogeneous-Nuclear Ribonucleoproteins chemistry, Heterogeneous-Nuclear Ribonucleoproteins metabolism, RNA Polymerase II, src Homology Domains, RNA-Binding Proteins genetics, Intellectual Disability genetics, Neuroblastoma, Deafness, Optic Atrophy, Seizures, Mental Retardation, X-Linked
- Abstract
RNA binding motif protein X-linked (RBMX) encodes the heterogeneous nuclear ribonucleoprotein G (hnRNP G) that regulates splicing, sister chromatid cohesion and genome stability. RBMX knock down experiments in various model organisms highlight the gene's importance for brain development. Deletion of the RGG/RG motif in hnRNP G has previously been associated with Shashi syndrome, however involvement of other hnRNP G domains in intellectual disability remain unknown. In the current study, we present the underlying genetic and molecular cause of Gustavson syndrome. Gustavson syndrome was first reported in 1993 in a large Swedish five-generation family presented with profound X-linked intellectual disability and an early death. Extensive genomic analyses of the family revealed hemizygosity for a novel in-frame deletion in RBMX in affected individuals (NM_002139.4; c.484_486del, p.(Pro162del)). Carrier females were asymptomatic and presented with skewed X-chromosome inactivation, indicating silencing of the pathogenic allele. Affected individuals presented minor phenotypic overlap with Shashi syndrome, indicating a different disease-causing mechanism. Investigation of the variant effect in a neuronal cell line (SH-SY5Y) revealed differentially expressed genes enriched for transcription factors involved in RNA polymerase II transcription. Prediction tools and a fluorescence polarization assay imply a novel SH3-binding motif of hnRNP G, and potentially a reduced affinity to SH3 domains caused by the deletion. In conclusion, we present a novel in-frame deletion in RBMX segregating with Gustavson syndrome, leading to disturbed RNA polymerase II transcription, and potentially reduced SH3 binding. The results indicate that disruption of different protein domains affects the severity of RBMX-associated intellectual disabilities., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
226. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
- Author
-
Sobol M, Klar J, Laan L, Shahsavani M, Schuster J, Annerén G, Konzer A, Mi J, Bergquist J, Nordlund J, Hoeber J, Huss M, Falk A, and Dahl N
- Subjects
- Cell Differentiation genetics, Cell Proliferation genetics, Female, Humans, Male, Mitochondria genetics, Models, Biological, Neurites metabolism, Neurogenesis genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Reactive Oxygen Species metabolism, Time Factors, Transcription, Genetic, Down Syndrome genetics, Down Syndrome pathology, Induced Pluripotent Stem Cells pathology, Neurons metabolism, Neurons pathology, Proteome metabolism, Transcriptome genetics
- Abstract
Down syndrome (DS) or trisomy 21 (T21) is a leading genetic cause of intellectual disability. To gain insights into dynamics of molecular perturbations during neurogenesis in DS, we established a model using induced pluripotent stem cells (iPSC) with transcriptome profiles comparable to that of normal fetal brain development. When applied on iPSCs with T21, transcriptome and proteome signatures at two stages of differentiation revealed strong temporal dynamics of dysregulated genes, proteins and pathways belonging to 11 major functional clusters. DNA replication, synaptic maturation and neuroactive clusters were disturbed at the early differentiation time point accompanied by a skewed transition from the neural progenitor cell stage and reduced cellular growth. With differentiation, growth factor and extracellular matrix, oxidative phosphorylation and glycolysis emerged as major perturbed clusters. Furthermore, we identified a marked dysregulation of a set of genes encoded by chromosome 21 including an early upregulation of the hub gene APP, supporting its role for disturbed neurogenesis, and the transcription factors OLIG1, OLIG2 and RUNX1, consistent with deficient myelination and neuronal differentiation. Taken together, our findings highlight novel sequential and differentiation-dependent dynamics of disturbed functions, pathways and elements in T21 neurogenesis, providing further insights into developmental abnormalities of the DS brain.
- Published
- 2019
- Full Text
- View/download PDF
227. TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish.
- Author
-
Gudmundsson S, Wilbe M, Filipek-Górniok B, Molin AM, Ekvall S, Johansson J, Allalou A, Gylje H, Kalscheuer VM, Ledin J, Annerén G, and Bondeson ML
- Subjects
- Adolescent, Adult, Animals, Child, Child, Preschool, Female, Gene Expression Profiling, Gene Knockdown Techniques, Histone Acetyltransferases genetics, Humans, Male, Mental Retardation, X-Linked genetics, Nervous System embryology, Pedigree, TATA-Binding Protein Associated Factors genetics, Transcription Factor TFIID genetics, Zebrafish embryology, Zebrafish genetics, Zebrafish Proteins genetics, Histone Acetyltransferases physiology, Intellectual Disability genetics, Nervous System growth & development, TATA-Binding Protein Associated Factors physiology, Transcription Factor TFIID physiology, Zebrafish growth & development, Zebrafish Proteins physiology
- Abstract
The TATA-box binding protein associated factor 1 (TAF1) protein is a key unit of the transcription factor II D complex that serves a vital function during transcription initiation. Variants of TAF1 have been associated with neurodevelopmental disorders, but TAF1's molecular functions remain elusive. In this study, we present a five-generation family affected with X-linked intellectual disability that co-segregated with a TAF1 c.3568C>T, p.(Arg1190Cys) variant. All affected males presented with intellectual disability and dysmorphic features, while heterozygous females were asymptomatic and had completely skewed X-chromosome inactivation. We investigated the role of TAF1 and its association to neurodevelopment by creating the first complete knockout model of the TAF1 orthologue in zebrafish. A crucial function of human TAF1 during embryogenesis can be inferred from the model, demonstrating that intact taf1 is essential for embryonic development. Transcriptome analysis of taf1 zebrafish knockout revealed enrichment for genes associated with neurodevelopmental processes. In conclusion, we propose that functional TAF1 is essential for embryonic development and specifically neurodevelopmental processes.
- Published
- 2019
- Full Text
- View/download PDF
228. An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study.
- Author
-
Wester Oxelgren U, Westerlund J, Myrelid Å, Annerén G, Johansson L, Åberg M, Gustafsson J, and Fernell E
- Abstract
Purpose: To evaluate whether an intervention, targeting deficits in social communication, interaction and restricted activities in children and adolescents with Down syndrome and autism could lead to enhanced participation in family and school activities., Methods: The intervention included education for parents and school staff about autism, and workshops to identify social-communication and daily living activities that would be meaningful for the child to practice at home and at school. Thereafter, a three-month period of training for the child followed. Outcome measures comprised evaluation of goal achievement for each child, the "Family Strain Index" questionnaire and a visual scale pertaining to the parents' general opinion about the intervention., Results: On average, more than 90% of the goals were (to some extent or completely) achieved at home and at school. The mean scores of the "Family Strain Index" were almost identical at the follow-up to those before intervention. The evaluation supported that the use of strategies, intended to facilitate activities and communication, remained largely 18 months after start of the intervention., Conclusion: Despite the group involved in this study being composed of older children and adolescents, most of whom had severe and profound intellectual disability, the goal achievements and parents' views on the intervention were encouraging., Competing Interests: The authors report no conflicts of interest in this work.
- Published
- 2019
- Full Text
- View/download PDF
229. A novel approach using long-read sequencing and ddPCR to investigate gonadal mosaicism and estimate recurrence risk in two families with developmental disorders.
- Author
-
Wilbe M, Gudmundsson S, Johansson J, Ameur A, Stattin EL, Annerén G, Malmgren H, Frykholm C, and Bondeson ML
- Subjects
- Female, Humans, Male, Mosaicism, Pregnancy, Preimplantation Diagnosis, Risk Assessment, DNA Mutational Analysis methods, Mandibulofacial Dysostosis diagnosis, Noonan Syndrome diagnosis, Nuclear Proteins genetics, Phosphoproteins genetics, Protein Tyrosine Phosphatase, Non-Receptor Type 11 genetics
- Abstract
Objective: De novo mutations contribute significantly to severe early-onset genetic disorders. Even if the mutation is apparently de novo, there is a recurrence risk due to parental germ line mosaicism, depending on in which gonadal generation the mutation occurred., Methods: We demonstrate the power of using SMRT sequencing and ddPCR to determine parental origin and allele frequencies of de novo mutations in germ cells in two families whom had undergone assisted reproduction., Results: In the first family, a TCOF1 variant c.3156C>T was identified in the proband with Treacher Collins syndrome. The variant affects splicing and was determined to be of paternal origin. It was present in <1% of the paternal germ cells, suggesting a very low recurrence risk. In the second family, the couple had undergone several unsuccessful pregnancies where a de novo mutation PTPN11 c.923A>C causing Noonan syndrome was identified. The variant was present in 40% of the paternal germ cells suggesting a high recurrence risk., Conclusions: Our findings highlight a successful strategy to identify the parental origin of mutations and to investigate the recurrence risk in couples that have undergone assisted reproduction with an unknown donor or in couples with gonadal mosaicism that will undergo preimplantation genetic diagnosis., (© 2017 The Authors Prenatal Diagnosis published by John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
230. Why do pregnant women accept or decline prenatal diagnosis for Down syndrome?
- Author
-
Ternby E, Axelsson O, Annerén G, Lindgren P, and Ingvoldstad C
- Abstract
To investigate if actual knowledge of Down syndrome (DS), influences the decision to accept or decline prenatal diagnosis (PND). Secondary aims were to elucidate reasons for accepting or declining PND and investigate differences between the accepting and declining group in perceived information, knowing someone with DS and thoughts about decision-making. A questionnaire was completed by 76 pregnant women who underwent invasive testing and 65 women who declined tests for chromosomal aberrations in Uppsala, Sweden. Apart from one question no significant differences were found in knowledge of DS between women declining or accepting PND for DS. Both groups had varying and in several respects low levels of knowledge about DS and its consequences. Most common reasons to accept PND were 'to ease my worries' and 'to do all possible tests to make sure the baby is healthy'. Corresponding statements declining PND were 'termination of pregnancy is not an option' and 'because invasive tests increase the risk of miscarriage'. More women declining PND knew someone with DS. Knowledge of DS at these levels is not a major factor when women decide to accept or decline PND for DS. Their choice is mostly based on opinions and moral values.
- Published
- 2016
- Full Text
- View/download PDF
231. 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency.
- Author
-
Linhares ND, Freire MC, Cardenas RG, Pena HB, Lachlan K, Dallapiccola B, Bacino C, Delobel B, James P, Thuresson AC, Annerén G, and Pena SD
- Abstract
Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.
- Published
- 2016
- Full Text
- View/download PDF
232. Midwives and information on prenatal testing with focus on Down syndrome.
- Author
-
Ternby E, Ingvoldstad C, Annerén G, and Axelsson O
- Subjects
- Cross-Sectional Studies, Female, Humans, Mass Screening, Middle Aged, Prospective Studies, Down Syndrome diagnosis, Health Knowledge, Attitudes, Practice, Midwifery statistics & numerical data, Prenatal Diagnosis
- Abstract
Objective: To investigate midwives' knowledge of prenatal diagnosis especially Down syndrome, information given by midwives to parents, expectant parents' requests for information and how midwives perceive their own competence to give information., Method: A cross-sectional, prospective study with a questionnaire was completed by 64 out of 70 midwives working in the outpatient antenatal care in Uppsala County, Sweden., Results: The midwives had varying and in some areas low levels of knowledge about Down syndrome. Information about Down syndrome was most often given only when asked for or when there was an increased probability of a Down syndrome pregnancy. The most common questions from expectant parents concerned test methods and risk assessments while questions regarding symptoms of Down syndrome and consequences of having a child with Down syndrome were uncommon. The majority (83-89%) had insufficient or no education regarding different prenatal tests. Only two midwives (3%) had received education about Down syndrome, and 9% felt they had sufficient knowledge to inform about the syndrome. More education about prenatal tests and Down syndrome was desired by 94%., Conclusion: It is important to ensure that midwives in antenatal care have sufficient knowledge to inform expectant parents about the conditions screened for. © 2015 John Wiley & Sons, Ltd., (© 2015 John Wiley & Sons, Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
233. A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype.
- Author
-
Terhal PA, Nievelstein RJ, Verver EJ, Topsakal V, van Dommelen P, Hoornaert K, Le Merrer M, Zankl A, Simon ME, Smithson SF, Marcelis C, Kerr B, Clayton-Smith J, Kinning E, Mansour S, Elmslie F, Goodwin L, van der Hout AH, Veenstra-Knol HE, Herkert JC, Lund AM, Hennekam RC, Mégarbané A, Lees MM, Wilson LC, Male A, Hurst J, Alanay Y, Annerén G, Betz RC, Bongers EM, Cormier-Daire V, Dieux A, David A, Elting MW, van den Ende J, Green A, van Hagen JM, Hertel NT, Holder-Espinasse M, den Hollander N, Homfray T, Hove HD, Price S, Raas-Rothschild A, Rohrbach M, Schroeter B, Suri M, Thompson EM, Tobias ES, Toutain A, Vreeburg M, Wakeling E, Knoers NV, Coucke P, and Mortier GR
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Cohort Studies, DNA Mutational Analysis, Female, Genetic Association Studies, Humans, Infant, Male, Middle Aged, Osteochondrodysplasias diagnostic imaging, Osteochondrodysplasias genetics, Radiography, Young Adult, Collagen Type II genetics, Mutation, Osteochondrodysplasias congenital, Phenotype
- Abstract
Type 2 collagen disorders encompass a diverse group of skeletal dysplasias that are commonly associated with orthopedic, ocular, and hearing problems. However, the frequency of many clinical features has never been determined. We retrospectively investigated the clinical, radiological, and genotypic data in a group of 93 patients with molecularly confirmed SEDC or a related disorder. The majority of the patients (80/93) had short stature, with radiological features of SEDC (n = 64), others having SEMD (n = 5), Kniest dysplasia (n = 7), spondyloperipheral dysplasia (n = 2), or Torrance-like dysplasia (n = 2). The remaining 13 patients had normal stature with mild SED, Stickler-like syndrome or multiple epiphyseal dysplasia. Over 50% of the patients had undergone orthopedic surgery, usually for scoliosis, femoral osteotomy or hip replacement. Odontoid hypoplasia was present in 56% (95% CI 38-74) and a correlation between odontoid hypoplasia and short stature was observed. Atlanto-axial instability, was observed in 5 of the 18 patients (28%, 95% CI 10-54) in whom flexion-extension films of the cervical spine were available; however, it was rarely accompanied by myelopathy. Myopia was found in 45% (95% CI 35-56), and retinal detachment had occurred in 12% (95% CI 6-21; median age 14 years; youngest age 3.5 years). Thirty-two patients complained of hearing loss (37%, 95% CI 27-48) of whom 17 required hearing aids. The ophthalmological features and possibly also hearing loss are often relatively frequent and severe in patients with splicing mutations. Based on clinical findings, age at onset and genotype-phenotype correlations in this cohort, we propose guidelines for the management and follow-up in this group of disorders., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
234. MuSK: a new target for lethal fetal akinesia deformation sequence (FADS).
- Author
-
Wilbe M, Ekvall S, Eurenius K, Ericson K, Casar-Borota O, Klar J, Dahl N, Ameur A, Annerén G, and Bondeson ML
- Subjects
- Abnormalities, Multiple physiopathology, Arthrogryposis physiopathology, Exome genetics, Female, Fetal Growth Retardation genetics, Fetal Growth Retardation physiopathology, Fetus physiopathology, Haplotypes, High-Throughput Nucleotide Sequencing, Humans, Infant, Newborn, Male, Mutation, Neuromuscular Junction growth & development, Neuromuscular Junction physiopathology, Pedigree, Signal Transduction, Abnormalities, Multiple genetics, Arthrogryposis genetics, Neuromuscular Junction genetics, Receptor Protein-Tyrosine Kinases genetics, Receptors, Cholinergic genetics
- Abstract
Background: Fetal akinesia deformation sequence syndrome (FADS, OMIM 208150) is characterised by decreased fetal movement (fetal akinesia) as well as intrauterine growth restriction, arthrogryposis, and developmental anomalies (eg, cystic hygroma, pulmonary hypoplasia, cleft palate, and cryptorchidism). Mutations in components of the acetylcholine receptor (AChR) pathway have previously been associated with FADS., Methods and Results: We report on a family with recurrent fetal loss, where the parents had five affected fetuses/children with FADS and one healthy child. The fetuses displayed no fetal movements from the gestational age of 17 weeks, extended knee joints, flexed hips and elbows, and clenched hands. Whole exome sequencing of one affected fetus and the parents was performed. A novel homozygous frameshift mutation was identified in muscle, skeletal receptor tyrosine kinase (MuSK), c.40dupA, which segregated with FADS in the family. Haplotype analysis revealed a conserved haplotype block suggesting a founder mutation. MuSK (muscle-specific tyrosine kinase receptor), a component of the AChR pathway, is a main regulator of neuromuscular junction formation and maintenance. Missense mutations in MuSK have previously been reported to cause congenital myasthenic syndrome (CMS) associated with AChR deficiency., Conclusions: To our knowledge, this is the first report showing that a mutation in MuSK is associated with FADS. The results support previous findings that CMS and/or FADS are caused by complete or severe functional disruption of components located in the AChR pathway. We propose that whereas milder mutations of MuSK will cause a CMS phenotype, a complete loss is lethal and will cause FADS., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.)
- Published
- 2015
- Full Text
- View/download PDF
235. A maternal de novo non-reciprocal translocation results in a 6q13-q16 deletion in one offspring and a 6q13-q16 duplication in another.
- Author
-
Wentzel C, Annerén G, and Thuresson AC
- Subjects
- Child, Chromosome Banding, Chromosome Disorders genetics, Chromosome Disorders pathology, DNA Copy Number Variations, Female, Humans, In Situ Hybridization, Fluorescence, Infant, Newborn, Male, Microarray Analysis methods, Mothers, Phenotype, Siblings, Chromosome Deletion, Chromosome Duplication, Chromosomes, Human, Pair 15 genetics, Chromosomes, Human, Pair 16 genetics, Translocation, Genetic
- Abstract
Here we report a case of two siblings with reciprocal aberrations, one presenting with a deletion and the other carrying two novel duplications at 6q13q16.1. Interestingly, both alterations were inherited from a healthy mother carrying a non-reciprocal translocation of 6q13q16 to 15q11. Deletions at 6q13q16.1 have been previously described; however this is the first characterisation of a 6q13q16.1 duplication. In this report we provide a comprehensive molecular and phenotypical characterisation of the affected siblings and discuss the profiles of previously identified patients carrying 6q deletions., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
236. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
- Author
-
Ekvall S, Sjörs K, Jonzon A, Vihinen M, Annerén G, and Bondeson ML
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, DNA Mutational Analysis, Facies, Female, Genotype, Humans, Male, Middle Aged, Pedigree, Phenotype, Young Adult, Genetic Association Studies, Mutation, Neurofibromatoses diagnosis, Neurofibromatoses genetics, Neurofibromatosis 1 diagnosis, Neurofibromatosis 1 genetics, Noonan Syndrome diagnosis, Noonan Syndrome genetics
- Abstract
Neurofibromatosis-Noonan syndrome (NFNS) is a rare condition with clinical features of both neurofibromatosis type 1 (NF1) and Noonan syndrome (NS). All three syndromes belong to the RASopathies, which are caused by dysregulation of the RAS-MAPK pathway. The major gene involved in NFNS is NF1, but co-occurring NF1 and PTPN11 mutations in NFNS have been reported. Knowledge about possible involvement of additional RASopathy-associated genes in NFNS is, however, very limited. We present a comprehensive clinical and molecular analysis of eight affected individuals from three unrelated families displaying features of NF1 and NFNS. The genetic etiology of the clinical phenotypes was investigated by mutation analysis, including NF1, PTPN11, SOS1, KRAS, NRAS, BRAF, RAF1, SHOC2, SPRED1, MAP2K1, MAP2K2, and CBL. All three families harbored a heterozygous NF1 variant, where the first family had a missense variant, c.5425C>T;p.R1809C, the second family a recurrent 4bp-deletion, c.6789_6792delTTAC;p.Y2264Tfs*6, and the third family a splice-site variant, c.2991-1G>A, resulting in skipping of exon 18 and an in-frame deletion of 41 amino acids. These NF1 variants have all previously been reported in NF1 patients. Surprisingly, both c.6789_6792delTTAC and c.2991-1G>A are frequently associated with NF1, but association to NFNS has, to our knowledge, not previously been reported. Our results support the notion that NFNS represents a variant of NF1, genetically distinct from NS, and is caused by mutations in NF1, some of which also cause classical NF1. Due to phenotypic overlap between NFNS and NS, we propose screening for NF1 mutations in NS patients, preferentially when café-au-lait spots are present., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
237. Changes in mortality and causes of death in the Swedish Down syndrome population.
- Author
-
Englund A, Jonsson B, Zander CS, Gustafsson J, and Annerén G
- Subjects
- Adolescent, Adult, Age Factors, Child, Child, Preschool, Down Syndrome mortality, Female, Humans, Infant, Male, Middle Aged, Registries, Sweden epidemiology, Young Adult, Cause of Death, Down Syndrome epidemiology, White People
- Abstract
During the past few decades age at death for individuals with Down syndrome (DS) has increased dramatically. The birth frequency of infants with DS has long been constant in Sweden. Thus, the prevalence of DS in the population is increasing. The aim of the present study was to analyze mortality and causes of death in individuals with DS during the period 1969-2003. All individuals with DS that died between 1969 and 2003 in Sweden, and all individuals born with DS in Sweden between 1974 and 2003 were included. Data were obtained from the Swedish Medical Birth Register, the Swedish Birth Defects Register, and the National Cause of Death Register. Median age at death has increased by 1.8 years per year. The main cause of death was pneumonia. Death from congenital heart defects decreased. Death from atherosclerosis was rare but more frequent than reported previously. Dementia was not reported in any subjects with DS before 40 years of age, but was a main or contributing cause of death in 30% of the older subjects. Except for childhood leukemia, cancer as a cause of death was rare in all age groups. Mortality in DS, particularly infant mortality, has decreased markedly during the past decades. Median age at death is increasing and is now almost 60 years. Death from cancer is rare in DS, but death from dementia is common., (Copyright © 2013 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
238. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
- Author
-
Ekvall S, Hagenäs L, Allanson J, Annerén G, and Bondeson ML
- Subjects
- Base Sequence, Child, DNA Mutational Analysis, Female, Humans, Molecular Sequence Data, Mutation genetics, Pedigree, Intracellular Signaling Peptides and Proteins genetics, Noonan Syndrome genetics, Noonan Syndrome pathology, Phenotype, Protein Tyrosine Phosphatase, Non-Receptor Type 11 genetics
- Abstract
Noonan syndrome (NS) is a heterogeneous disorder caused by activating mutations in the RAS-MAPK signaling pathway. It is associated with variable clinical expression including short stature, congenital heart defect, unusual pectus deformity, and typical facial features and the inheritance is autosomal dominant. Here, we present a clinical and molecular characterization of a patient with Noonan-like syndrome with loose anagen hair phenotype and additional features including mild psychomotor developmental delay, osteoporosis, gingival hyperplasia, spinal neuroblastoma, intrathoracic extramedullary hematopoiesis, and liver hemangioma. Mutation analysis of PTPN11, SOS1, RAF1, KRAS, BRAF, MEK1, MEK2, NRAS, and SHOC2 was conducted, revealing a co-occurrence of two heterozygous previously identified mutations in the index patient. The mutation SHOC2 c.4A > G; p.Ser2Gly represents a de novo mutation, whereas, PTPN11 c.1226G > C; p.Gly409Ala was inherited from the mother and also identified in the brother. The mother and the brother present with some NS manifestations, such as short stature, delayed puberty, keratosis pilaris, café-au-lait spots, refraction error (mother), and undescended testis (brother), but no NS facial features, supporting the notion that the PTPN11 p.Gly409Ala mutation leads to a relatively mild phenotype. We propose that, the atypical phenotype of the young woman with NS reported here is an additive effect, where the PTPN11 mutation acts as a modifier. Interestingly, co-occurrence of RAS-MAPK mutations has been previously identified in a few patients with variable NS or neurofibromatosis-NS phenotypes. Taken together, the results suggest that co-occurrence of mutations or modifying loci in the RAS-MAPK pathway may contribute to the clinical variability observed among NS patients., (Copyright © 2011 Wiley-Liss, Inc.)
- Published
- 2011
- Full Text
- View/download PDF
239. Cardio-facio-cutaneous syndrome: does genotype predict phenotype?
- Author
-
Allanson JE, Annerén G, Aoki Y, Armour CM, Bondeson ML, Cave H, Gripp KW, Kerr B, Nystrom AM, Sol-Church K, Verloes A, and Zenker M
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Cohort Studies, Ectodermal Dysplasia genetics, Ectodermal Dysplasia pathology, Facies, Failure to Thrive genetics, Failure to Thrive pathology, Female, Genotype, Heart Defects, Congenital genetics, Heart Defects, Congenital pathology, Humans, Infant, Infant, Newborn, Male, Mutation genetics, Genetic Predisposition to Disease genetics, MAP Kinase Kinase 1 genetics, MAP Kinase Kinase 2 genetics, Phenotype, Proto-Oncogene Proteins B-raf genetics, Pulmonary Valve Stenosis genetics
- Abstract
Cardio-facio-cutaneous (CFC) syndrome is a sporadic multiple congenital anomalies/mental retardation condition principally caused by mutations in BRAF, MEK1, and MEK2. Mutations in KRAS and SHOC2 lead to a phenotype with overlapping features. In approximately 10–30% of individuals with a clinical diagnosis of CFC, a mutation in one of these causative genes is not found. Cardinal features of CFC include congenital heart defects, a characteristic facial appearance, and ectodermal abnormalities. Additional features include failure to thrive with severe feeding problems, moderate to severe intellectual disability and short stature with relative macrocephaly. First described in 1986, more than 100 affected individuals are reported. Following the discovery of the causative genes, more information has emerged on the breadth of clinical features. Little, however, has been published on genotype–phenotype correlations. This clinical study of 186 children and young adults with mutation-proven CFC syndrome is the largest reported to date. BRAF mutations are documented in 140 individuals (approximately 75%), while 46 (approximately 25%) have a mutation in MEK 1 or MEK 2. The age range is 6 months to 32 years, the oldest individual being a female from the original report [Reynolds et al. (1986); Am J Med Genet 25:413–427]. While some clinical data on 136 are in the literature, 50 are not previously published. We provide new details of the breadth of phenotype and discuss the frequency of particular features in each genotypic group. Pulmonary stenosis is the only anomaly that demonstrates a statistically significant genotype–phenotype correlation, being more common in individuals with a BRAF mutation.
- Published
- 2011
- Full Text
- View/download PDF
240. [Better support to first-time parents of children with life-long functional disabilities. Proposal to new guidelines].
- Author
-
Hedov G and Annerén G
- Subjects
- Access to Information, Down Syndrome diagnosis, Genetic Diseases, Inborn diagnosis, Genetic Diseases, Inborn psychology, Guidelines as Topic, Humans, Infant, Newborn, Parents education, Professional-Family Relations, Sweden, Truth Disclosure, Disabled Children psychology, Down Syndrome psychology, Parents psychology, Social Support
- Published
- 2010
241. [Children and adolescents with Down syndrome. Continuous ophthalmological monitoring crucial!].
- Author
-
Jönelid B, Annerén G, and Holmström G
- Subjects
- Accommodation, Ocular, Adolescent, Cataract congenital, Cataract diagnosis, Child, Child, Preschool, Down Syndrome complications, Down Syndrome physiopathology, Follow-Up Studies, Humans, Infant, Infant, Newborn, Practice Guidelines as Topic, Quality of Life, Refraction, Ocular, Regional Medical Programs, Vision Disorders etiology, Down Syndrome diagnosis, Vision Disorders diagnosis, Vision Tests methods
- Abstract
Children with Down's syndrome are at increased risk of ocular manifestations, which is confirmed by a study in Uppsala, Sweden. Sixty percent of the children were wearing glasses and/or had other ocular problems. However, lapses were found in follow-up and referral to the eye clinic. Good visual function is an important prerequisite for optimal quality of life of children and adults with Down's syndrome. Since this group does not always spontaneously get in touch with the health care system including ophthalmologists, the infant must be referred by the pediatrician immediately after birth. The number of individuals with Down's syndrome in Sweden is large (3,500-5,000), and an ophthalmological follow-up program, as presented in this paper, is of key importance.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.